SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
141.60    -24.20 (-14.60%)
Bid:
140.20
Ask:
144.80
Spread: 4.60 (3.281%)
Market Cap: £241.94m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Trading Update

10 Jan 2019 07:00

RNS Number : 6695M
McBride PLC
10 January 2019
 

10 January 2019

 

McBride plc

 

Trading Update

 

McBride plc (the "Group"), the leading European manufacturer and supplier of Contract Manufactured and Private Label products for the domestic Household and professional cleaning and hygiene markets, today provides a trading update for the six months ended 31 December 2018.

 

The Group's first half continuing revenues at constant currency were 10.8% higher than the prior year. Excluding the benefit of first quarter revenues from Danlind, continuing underlying revenues were 6.0% higher. Underlying Household division sales were 5.9% higher, primarily as a result of higher sales in the East and UK regions (up 23.4% and 10.5% respectively).

 

As outlined in our recent AGM trading update, the first half year has seen raw material, packaging and logistics costs higher than anticipated, particularly in the second quarter. These have been partly mitigated by improved sales volumes and lower overheads. The pricing outlook for many of our key raw materials has improved recently and in the absence of this reversing significantly, the Board expects full year earnings to be in line with expectations, with full year profit delivery weighted to the second half.

The sale of the European Personal Care Liquids business was successfully completed during the second quarter and we continue to progress plans for the closure of our UK Aerosols factory in the second half year as expected. The integration of Danlind continued with our Danish factories transitioning onto the McBride ERP system in December.

 

The Group will announce its interim results for the six months ended 31 December 2018 on 21 February.

 

Rik De Vos, Chief Executive said;

 

"The Group has made significant strategic progress in the first half of this financial year completing the sale of Personal Care Liquids, integrating Danlind onto the McBride systems and managing our revenue growth. Margins remain our key focus at present and the recent improvement in the pricing outlook for raw materials following almost two years of significant inflation will see some recovery of the cumulative cost impact to the business. I remain confident that the Group continues to be well positioned to exploit the growth and margin opportunities in the remainder of this financial year and beyond."

 

 

For further information please contact:

 

McBride plc

Rik De Vos, Chief Executive Officer

0161 203 7570

Chris Smith, Chief Financial Officer

0161 203 7570

FTI Consulting

020 3727 1017

Ed Bridges, Nick Hasell

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

 

-Ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTQKLFBKFFLBBV
Date   Source Headline
5th Jan 20157:00 amRNSTrading Update
18th Dec 20147:00 amRNSBoard Changes
1st Dec 20145:04 pmRNSIssue of B Shares
21st Nov 20149:12 amRNSHolding(s) in Company
11th Nov 201412:46 pmRNSHolding(s) in Company
21st Oct 201410:25 amRNSResult of AGM
20th Oct 20144:08 pmRNSAppointment of Chief Finance Officer
20th Oct 20147:00 amRNSAGM and Interim Management Statement
29th Sep 201412:56 pmRNSDirector/PDMR Shareholding
19th Sep 20147:01 amRNSTotal Voting Rights
19th Sep 20147:00 amRNSAnnual Report and Accounts
15th Sep 201412:25 pmRNSDirector/PDMR Shareholding
11th Sep 20143:24 pmRNSDate of Payments to Shareholders
10th Sep 20147:00 amRNSFinal Results
15th Jul 20147:00 amRNSAppointment of new Executive Director
8th Jul 20145:00 pmRNSHolding(s) in Company
30th Jun 20147:00 amRNSTrading Update
2nd Jun 20143:06 pmRNSIssue of B class shares & Total Voting Rights
29th May 20144:32 pmRNSHolding(s) in Company
29th May 20143:50 pmRNSHolding(s) in Company
25th Apr 201412:40 pmRNSHolding(s) in Company
15th Apr 201410:04 amRNSHolding(s) in Company
14th Apr 20149:10 amRNSHolding(s) in Company
9th Apr 20147:00 amRNSCompletion of Refinancing
8th Apr 20144:40 pmRNSDirector/PDMR Shareholding
7th Apr 201411:17 amRNSDirector/PDMR Shareholding
4th Apr 20143:02 pmRNSDirector/PDMR Shareholding
18th Mar 20149:16 amRNSHolding(s) in Company
10th Mar 20144:59 pmRNSDirector Declaration
14th Feb 20149:27 amRNSHolding(s) in Company
11th Feb 20147:00 amRNSForthcoming Directorate Change
11th Feb 20147:00 amRNSHalf Yearly Report
9th Jan 20147:00 amRNSTrading Update
20th Dec 20132:53 pmRNSHolding(s) in Company
20th Dec 20131:29 pmRNSHolding(s) in Company
9th Dec 20138:36 amRNSHolding(s) in Company
3rd Dec 201310:13 amRNSHolding(s) in Company
2nd Dec 20134:31 pmRNSIssue of B Shares
1st Nov 20134:31 pmRNSHolding(s) in Company
1st Nov 20138:47 amRNSHolding(s) in Company
18th Oct 201312:58 pmRNSHolding(s) in Company
15th Oct 201311:24 amRNSResult of AGM
14th Oct 20137:00 amRNSAGM and Interim Management Statement
11th Oct 20139:19 amRNSChange of Registered Office
17th Sep 20133:41 pmRNSDirector/PDMR Shareholding
13th Sep 20139:03 amRNSAnnual Report and Accounts
13th Sep 20139:03 amRNSTotal Voting Rights
4th Sep 20138:56 amRNSDirector/PDMR Shareholding
3rd Sep 20137:00 amRNSFinal Results
5th Jul 20137:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.